About us
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis.
Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
Reports and presentations
2023
Half-Year Financial Report 2023
2022
Annual report 2022
Financial Statement release 2022
Half-Year Financial report 2022
© BIOHIT Healthcare Oyj